Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study.
Saved in:
| Title: | Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study. |
|---|---|
| Authors: | Litwin AH; School of Health Research, Clemson University, Clemson, South Carolina.; Department of Medicine, University of South Carolina School of Medicine, Greenville.; Department of Medicine, Prisma Health, Greenville, South Carolina., Tsui JI; Department of Medicine, University of Washington, Seattle., Heo M; Department of Public Health Sciences, Clemson University, Clemson, South Carolina., Mehta SH; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Taylor LE; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston., Lum PJ; Department of Medicine, University of California, San Francisco., Feinberg J; Department of Behavioral Medicine and Psychiatry, West Virginia University School of Medicine, Morgantown.; Department of Medicine, Section of Infectious Diseases, West Virginia University School of Medicine, Morgantown., Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston., Norton BL; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Pericot-Valverde I; Department of Psychology, College of Behavioral, Social, and Health Sciences, Clemson University, Clemson, South Carolina., Arnsten J; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Meissner P; Department of Family and Social Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Karasz A; Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester., McKee MD; Department of Family Medicine & Community Health, University of Massachusetts Chan Medical School, Worcester., Ward JW; Coalition for Global Hepatitis Elimination, The Task Force for Global Health, Decatur, Georgia., Johnson N; New York City Department of Health and Mental Hygiene, New York, New York., Agyemang L; Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York., Stein ES; Department of Medicine, University of California, San Francisco., Thomas A; Department of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston., Borsuk C; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Blalock KL; Department of Medicine, University of Washington, Seattle., Wilkinson S; Office of Research Program Management, West Virginia University, Morgantown., Wagner K; Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque., Carty J; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston., Murray-Krezan C; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Anderson J; Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque., Jacobsohn V; Department of Psychiatry and Behavioral Sciences, University of New Mexico School of Medicine, Albuquerque., Luetkemeyer AF; Department of Medicine, University of California, San Francisco., Falade-Nwulia O; Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland., Groome M; Department of Medicine, Prisma Health, Greenville, South Carolina., Davies S; Center for Health Law & Policy Innovation, Harvard Law School, Cambridge, Massachusetts., Costello K; Center for Health Law & Policy Innovation, Harvard Law School, Cambridge, Massachusetts., Page K; Department of Internal Medicine, University of New Mexico Health Sciences Center, University of New Mexico, Albuquerque. |
| Corporate Authors: | HERO Study Group |
| Source: | JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2430024. Date of Electronic Publication: 2024 Aug 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2024.30024 |
